To get deals in your inbox each morning, sign up for our Term Sheet newsletter
CAN Capital, an online provider of small business capital, has raised $33 million in new VC funding.Meritech Capital Partners led the round, and was joined by Ribbit Capital, QED Investors and return backer Accel Partners. www.cancapital.com
Aquion Energy Inc., a Pittsburgh-based developer of water-based sodium ion batteries, has raised $20 million in additional Series D funding, bringing the round total to $55 million. New backers include Bill Gates, Yung’s Enterprise, Tao Invest, Bright Capital and Gentry Venture Partners. Return backers include Kleiner Perkins Caufield & Byers, Foundation Capital, and Advanced Technology Ventures.www.aquionenergy.com
Radius Intelligence, a San Francisco-based data technology company for B2B marketers, has raised $13 million in new VC funding led by Formation8 Partners, according to VentureWire. The company previously raised $12.4 million from American Express, BBVA Ventures, BlueRun Ventures, Comcast Ventures and Western Technology Investment. www.radius.com
PlanSource, an Orlando, Fla.-based provider of on-demand software for healthcare and employee benefits sales and management, has raised $12 million in Series B funding from return backers Lemhi Ventures and Timucuan Asset Management. www.plansource.com
Compliance Science Inc., a provider of web-based regulatory compliance technology and services, has raised $8.25 million in Series A funding from Edison Ventures. www.complysci.com
Forus Health, an India-based developer of “affordable” ophthalmic technology and solutions, has raised $8.2 million in Series B funding. Asian Healthcare Fund led the round, and was joined by Accel Partners and IDG Ventures India. www.forushealth.com
Glooko, a Palo Alto, Calif.-based provider of a diabetes management app, has raised $7 million in Series A1 funding. Samsung Venture Investment Co. and Lifeforce Ventures were joined by return backers like The Social+Capital Partnership. www.glooko.com
Avelas Biosciences, a San Diego–based startup focused on visualizing cancerous lymph nodes in breast cancer patients, has raised $6.85 million in Series B funding. Existing backer Avalon Ventures led the round, and was joined by Torrey Pines Investment and WuXi AppTec. www.avelasbio.com
Private Equity Deals
Affinity Equity Partners has entered into exclusive negotiations to acquire juice bar chain operatorRetail Zoo from The Riverside Company, according to The Australian. UBS is managing the process. www.boostjuice.com.au
ComplexCare Solutions Inc., a New York–based provider of healthcare payer services, has raised $40 million in growth equity funding from Warburg Pincus. www.complexcaresolutions.com
Prospect Partners and Schilling Ventures have recapitalized Cyclonaire Corp., a York, Neb.–based provider of pneumatic conveying systems. No financial terms were disclosed.www.cyclonaire.com
Macquarie Group, TPG Capital and Vitol Group are considering bids for some of Royal Dutch Shell’s Australian downstream operations, according to Bloomberg. The deal could be valued at around $2.7 billion. www.shell.com
PetroSkills, a portfolio company of BV Investment Partners, has acquired Resource Development Co., a provider of e-learning content and software to the petroleum industry. No financial terms were disclosed. www.petroskills.com
Snap Fitness Inc., a Chanhassen, Minn.-based health club operator with around 2,000 locations open or under development, has raised an undisclosed amount of equity funding from TZP Capital Partners.www.snapfitness.com
TPG Growth has acquired PJ United, the largest franchisee of Papa John’s Pizza, from The Halifax Group. No financial terms were disclosed. www.papajohns.com
IPOs
Flexion Therapeutics Inc., a Woburn, Mass.-based developer of therapeutics for musculoskeletal disorders, has filed for an $86.25 million IPO. It plans to trade on the Nasdaq under ticker symbol FLXN, with BMO Capital Markets serving as lead underwriter. Shareholders include Versant Ventures (29.76% pre-IPO stake), Sofinnova Capital (19.25%), Pfizer Inc. (17.32%), 5AM Ventures (15.52%) and Novo AS (11.2%). www.flexiontherapeutics.com
KineMed, an Emeryville, Calif.-based developer of biomarker platform technology, has filed for a $48.3 million IPO. It plans to trade on the Nasdaq under ticker symbol KNMD, with H.C. Wainwright & Co. serving as lead underwriter. www.kinemed.com
Myriant Inc., a Quincy, Mass.-based developer of bio-chemicals that substitute for traditional petroleum-based industrial chemicals, has withdrawn registration for a $125 million IPO. No explanation was provided. Shareholders include Plainfield Asset Management and PTT Chemical International. www.myriant.com
Société d’Articles Hygiéniques, a Tunisian maker of feminine and baby hygiene products, has raised around $79 million in its IPO on the Tunis Stock Exchange. The float enabled an exit by company shareholder Emerging Capital Partners. www.ecpinvestments.com
OTHER DEALS
Dish Network Corp. (Nasdaq: DISH) is pulling its $2.2 billion offer for bankrupt wireless telecom company LightSquared, according to the WSJ. This comes less than one monh after Centerbridge Capital Partners walked away from a tentative agreement to buy Lightsquared, over regulatory concerns. www.lightsquared.com
Elliott Management has offered to acquire networking company Riverbed Technology (Nasdaq: RVBD) for $3.2 billion, or $19 per share (6.4% premium to Tuesday’s closing price). Elliott already owns just over 9% of outstanding Riverbed stock. www.riverbed.com
Glori Energy Inc., a Houston, Texas-based provider of biotech solutions to increase recovery from mature oil wells, is going public via a $185 million reverse merger with Infinity Cross Border Acquisition Corp. (Nasdaq: INXB). Infiniy’s sponsors are Infinity Group and Hicks Equity Partners, while Glori Energy backers include GTI Ventures (18.5% stake), Oxford Bioscience Partners (19%), The Ozmest Group (18.3%), Kleiner Perkins Caufield & Byers (15.7%), Malaysian Life Sciences Capital Fund (13.5%), Energy Technology Ventures (6.9%), Gentry Venture Partners and Advantage Capital Partners. www.glorioil.com
Facebook (Nasdaq: FB) has agreed to acquire Little Eye Labs, an Indian mobile analytics company for Android developers. No financial terms were disclosed. www.littleeye.co
Sign up for Dan Primack’s daily email newsletter on deals and deal-makers: GetTermSheet.com
